Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 8/20 | 0.55 |
| ▸ | RAB9A | P51151 | 7/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.55 |
| ▸ | POLB | P06746 | 3/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | ATM | Q13315 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | BLM | P54132 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3344444 | 0.86 | NPC1 (0.59) | NPC1RAB9AALDH1A1L3MBTL1POLB | |
| SCHEMBL10603927 | 0.81 | NPC1 (0.54) | NPC1RAB9AALDH1A1L3MBTL1POLB | |
| SCHEMBL10205813 | 0.81 | L3MBTL1 (0.56) | NPC1RAB9AALDH1A1L3MBTL1POLB | |
| SCHEMBL1874036 | 0.79 | NPC1 (0.54) | NPC1RAB9AALDH1A1L3MBTL1POLB | |
| SCHEMBL17298873 | 0.79 | NPC1 (0.52) | NPC1RAB9AALDH1A1L3MBTL1POLB | |
| SCHEMBL26048300 | 0.79 | NPC1 (0.59) | NPC1RAB9AALDH1A1L3MBTL1POLB | |
| SCHEMBL17052948 | 0.79 | LMNA (0.55) | NPC1RAB9AALDH1A1L3MBTL1POLB | |
| SCHEMBL753759 | 0.79 | ALDH1A1 (0.59) | NPC1RAB9AALDH1A1L3MBTL1POLB | |
| SCHEMBL2216041 | 0.77 | NPC1 (0.56) | NPC1RAB9AALDH1A1L3MBTL1POLB | |
| SCHEMBL30874242 | 0.77 | NPC1 (0.56) | NPC1RAB9AALDH1A1L3MBTL1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1514550-A2 | Combinations for diabetes which contain a sulfonylurea, a glitazone and a biguanide | WARNER-LAMBERT COMPANY LLC (US) | 2005-03-16 | — | — | EP | disclosed |
| EP-1128834-A1 | COMBINATIONS FOR DIABETES WHICH CONTAIN A SULFONYLUREA, A GLITAZONE AND A BIGUANIDE | WARNER-LAMBERT COMPANY (US) | 2001-09-05 | — | — | EP | disclosed |
| WO-2000027401-A1 | COMBINATIONS FOR DIABETES WHICH CONTAIN A SULFONYLUREA, A GLITAZONE AND A BIGUANIDE | WARNER-LAMBERT COMPANY (US) | 2000-05-18 | — | — | WO | disclosed |
| US-6011049-A | Combinations for diabetes | WARNER-LAMBERT COMPANY (US) | 2000-01-04 | — | — | US | disclosed |
| EP-0957923-A1 | SULFONYLUREA-GLITAZONE SYNERGISTIC COMBINATIONS FOR DIABETES | WARNER-LAMBERT COMPANY (US) | 1999-11-24 | — | — | EP | disclosed |
| US-5972973-A | SYNERGISTIC MIXTURE; GLUCOSE CONTROL | WARNER-LAMBERT COMPANY (US) | 1999-10-26 | — | — | US | disclosed |
| US-5859037-A | MIXTURE SYNERGISTIC FOR THE TREATMENT OF NON-INSULIN DEPENDENT DIABETES MELLITUS IN HUMANS, WHICH ALSO IMPROVES GLYCEMIC CONTROL | WARNER-LAMBERT COMPANY (US) | 1999-01-12 | — | — | US | disclosed |
| WO-1998036755-A1 | SULFONYLUREA-GLITAZONE SYNERGISTIC COMBINATIONS FOR DIABETES | WARNER LAMBERT COMPANY (US) | 1998-08-27 | — | — | WO | disclosed |